Demis Hassabis on Isomorphic’s $600 million raise, AI, and healthcare’s future
Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...
How a Love of Chess Led the CEO of Google's DeepMind to a Career in AI — and a Nobel Prize
Google DeepMind CEO Demis Hassabis's AI journey had an unexpected start: his early mastery of chess. Years before Hassabis ...
Google DeepMind CEO says his passion for chess led to his career in AI
Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...
DeepMind is holding back release of AI research to give Google an edge
Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...
University of Cambridge8d
Nobel laureate and Cambridge alumnus Sir Demis Hassabis heralds a new era of 'digital speed' drug discovery
Demis, who was last year jointly awarded the Nobel Prize in Chemistry with Google DeepMind colleague Dr John Jumper for their ...
Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
OfficeChai7d
AI Can Help Create Virtual Cells For Biological Research: Google DeepMind’s Demis Hassabis
AI is already changing how we work with computers, but it might also change how we interact with the human body. Demis ...
GlobalData on MSN1d
Google-backed Isomorphic Labs raises $600m to advance AI drug discovery
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
How David Baker is changing the world with new proteins
Dr David Baker's Nobel Prize-winning breakthrough of designing new proteins has the potential to stop cancers, pandemics, fix ...
AOL7d
Google DeepMind CEO says his passion for chess led to his career in AI
Demis Hassabis's first love wasn't AI — it was chess. Decades before the Google DeepMind CEO would be co-awarded the 2024 Nobel Prize in Chemistry — thanks to helping develop an AI tool that ...